Editas Medicine suspends ATM offering program; $43.9M raised to date

Editas Medicine, Inc.

Notified TD Cowen of suspension and termination of March 21, 2025 prospectus supplement.
No further ATM sales until new prospectus or registration statement is filed and effective.
Sales Agreement with TD Cowen remains in full force and effect.
Aggregate sales to date: 14,327,365 shares for $43.9M gross proceeds before expenses.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-066021
form_type: 8-K
ticker: EDIT
cik: 0001650664
company_name: Editas Medicine, Inc.
filed_at: 2026-05-26T12:07:16+00:00
discovered_at: 2026-05-26T12:10:02.424579+00:00
generated_at: 2026-05-26T12:10:28.373549+00:00
sec_items: ["8.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-066021
json_url: https://secwatch.observer/filing/0001104659-26-066021.json
markdown_url: https://secwatch.observer/filing/0001104659-26-066021.md
text_url: https://secwatch.observer/filing/0001104659-26-066021.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/0001104659-26-066021-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1650664/000110465926066021/tm2615565d2_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-26-066021

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.